Significance of APOB/APOA1 Ratio in the Prediction of Calcific Aortic Valve Disease
Cardiovascular Therapeutics · 2025-01 · 2025 (1)
DOI: 10.1155/cdr/5528174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cardiovascular Therapeutics, online erschienen am 04.08.2025. Verfasst von Yuxing Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China. Hauptthemen laut MEDLINE: Apolipoprotein A-I, Aortic Valve, Apolipoprotein B-100, Aortic Valve Stenosis. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Calcific aortic valve disease (CAVD) is a prevalent heart valve disease. The ratio of two apolipoproteins with distinct functions, Apolipoprotein B/Apolipoprotein A1 (APOB/APOA1), has been proposed as a novel assessment index for the evaluation of cardiovascular diseases. The aim of this article is to discuss the role of lipid parameters such as APOB/APOA1 in CAVD and the risk factors for CAVD, to develop a predictive model for CAVD, and to evaluate the sensitivity and specificity of this model.
Method
Patients who initially presented to the Department of Cardiology of the Second Affiliated Hospital of Dalian Medical University between 1 January 2023 and 31 December 2023 were retrospectively identified and included in the study. Patients were divided into an aortic valve calcification group (111 cases) and a control group (201 cases) based on computed tomography (CT) findings. The clinical data, laboratory examination results, and chest CT images of the patients were collected and analyzed. A variety of statistical methods were used to analyze risk factors for CAVD, to construct a CAVD prediction model, and to assess its sensitivity and specificity.
Results
Lipid parameters APOA1, APOB/APOA1, cumulative low‐density lipoprotein (LDL) exposure, and non–high‐density lipoprotein/high‐density lipoprotein (non‐HDL/HDL) were significantly associated with aortic valve calcification. Age, history of diabetes, diastolic blood pressure (DBP), APOB/APOA1, Cystatin C (Cys‐c), and neutrophil‐to‐lymphocyte ratio (NLR) are identified as independent risk factors for CAVD, and the combined model achieved an AUC of 0.796 for CAVD prediction, corresponding to a sensitivity of 0.769 and a specificity of 0.755.
Conclusion
The lipid parameters APOA1, APOB/APOA1, cumulative LDL exposure, and non‐HDL/HDL have been demonstrated to be associated with aortic valve calcification. Furthermore, APOB/APOA1 can be used for the prediction of CAVD, and the combination of APOB/APOA1 with age, history of diabetes, DBP, Cys‐c, and NLR has better prediction performance for CAVD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, The Second Hospital of Dalian Medical University, Dalian, Liaoning, China.
ORCID-Profile: Yuxing Wang, Ming Yu, Song Yang, Jiajie Mei, Zhenzhu Liu, Zhaohong Geng, Wenli Xie, Lijiao Zhang, Hongyan Wang, Nan Niu, Peng Qu
Zitieren
APA
Wang, Y., Yu, M., Yang, S., Mei, J., Liu, Z., Geng, Z., Xie, W., Zhang, L., Wang, H., Niu, N., & Qu, P. (2025). Significance of APOB/APOA1 Ratio in the Prediction of Calcific Aortic Valve Disease. Cardiovascular Therapeutics, 2025(1). https://doi.org/10.1155/cdr/5528174
Vancouver
Wang Y, Yu M, Yang S, Mei J, Liu Z, Geng Z, et al. Significance of APOB/APOA1 Ratio in the Prediction of Calcific Aortic Valve Disease. Cardiovascular Therapeutics. 2025;2025(1). doi:10.1155/cdr/5528174
BibTeX
@article{Wang2025,
author = {Wang, Yuxing and Yu, Ming and Yang, Song and Mei, Jiajie and Liu, Zhenzhu and Geng, Zhaohong and Xie, Wenli and Zhang, Lijiao and Wang, Hongyan and Niu, Nan and Qu, Peng},
title = {Significance of APOB/APOA1 Ratio in the Prediction of Calcific Aortic Valve Disease},
journal = {Cardiovascular Therapeutics},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/cdr/5528174}
}
EUVIMED